EMA (European
Medicines Agency) has published this proposed plan for advancing the Agency’s
engagement with regulatory science over the next five to ten years, covering
both human and veterinary medicines.
The
strategy includes developments and challenges in medicines development that EMA
together with the Commission and NCAs experts have identified in a thorough
process of
mapping
and selection. Now EMA wants to hear from stakeholders.
Posted by Dr. Tim Sandle,
Pharmaceutical Microbiology
No comments:
Post a Comment
Pharmaceutical Microbiology